Drug Markets/Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate

Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate

1 NDC across 1 manufacturer|0 Generic,1 Brand

▸ More about this market

Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $21.99 to $21.99 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$21.99 – $21.99

per ML

7d Activity

2-1 flat

avg -0.1% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing COLISTIN SULFATE, NEOMYCIN SULFATE, THONZONIUM BROMIDE AND HYDROCORTISONE ACETATE

Drug Portfolio

1 NDCs total, 1 shown

Drug Price 7d Change
CORTISPORIN-TC EAR SUSPENSION
$21.9856
per ML
-0.09%

Frequently Asked Questions

How many Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate products are on the market?

The Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate?

NADAC reference prices for Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate range from $21.9856 to $21.9856 per ML.

Which manufacturers make Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate?

1 manufacturer lists Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate in NADAC. Ranked by number of NDCs, the largest are Endo USA Inc. (1).

How has the price of Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate changed recently?

Over the past 7 days, 0 Colistin Sulfate, Neomycin Sulfate, Thonzonium Bromide and Hydrocortisone Acetate NDCs rose and 2 fell, with a market-wide average change of -0.1%.